```html

Ureteroenteric Fistula – A Comprehensive Medical Guide

Overview

Ureteroenteric fistula (UEF) is an abnormal connection between the ureter—the tube that carries urine from the kidney to the bladder—and any part of the gastrointestinal (GI) tract (e.g., small intestine, colon, or rectum). This rare condition allows urine to leak into the bowel and, conversely, bowel contents to enter the urinary system.

Because the ureters lie close to the bowel, most UEFs are iatrogenic, meaning they develop after surgical or interventional procedures. They can also arise from severe infections, radiation therapy, malignancy, or trauma.

Who It Affects

• Adults—the majority of cases occur in patients 45–75 years old.
• Patients who have had pelvic surgery—especially radical cystectomy, hysterectomy, prostatectomy, or bowel resection.
• Individuals receiving pelvic radiation for cancer (e.g., cervical, bladder, prostate) are at higher risk.

Prevalence

Ureteroenteric fistula is exceedingly uncommon; exact incidence is not well‑documented, but large tertiary centers report 0.5–2 % of patients undergoing urinary diversion develop a fistula within 5 years of surgery (Mayo Clinic, 2022). The rarity often leads to delayed diagnosis.

Symptoms

Symptoms can be subtle at first and may mimic other urologic or gastrointestinal problems. The combination of urinary and intestinal signs is a clue.

• Pneumaturia – passage of gas or “bubbles” in the urine; often described as a “fizzing” sensation.
• Fecaluria – stool odor or visible particulate matter in the urine.
• Urinary frequency, urgency, or dysuria – irritation from bowel content contamination.
• Flank or abdominal pain – may be dull or colicky, reflecting inflammation of the ureter or bowel.
• Recurrent urinary tract infections (UTIs) – often with unusual organisms such as Enterococcus, E. coli, Bacteroides, or fungi.
• Fecal incontinence or diarrhea – when the fistula empties into the colon/rectum.
• Unexplained weight loss or malnutrition – due to chronic infection or malabsorption.
• Skin irritation or cellulitis around the flank or perineum in cases of external urine leakage.
• Hematuria – blood in urine is less common but may occur if adjacent tissue is inflamed.

Causes and Risk Factors

Primary Causes

• Iatrogenic injury – inadvertent ureteral transection, ligation, or thermal injury during pelvic surgery.
• Radiation-induced fibrosis – chronic tissue damage leading to breakdown of the ureteral wall.
• Infection – severe pyelonephritis or diverticulitis can erode into adjoining structures.
• Malignancy – advanced colorectal, ovarian, or bladder cancer can infiltrate the ureter.
• Trauma – penetrating or blunt abdominal injury.

Risk Factors

• History of major pelvic or retroperitoneal surgery.
• Pelvic radiation therapy (> 45 Gy).
• Chronic indwelling ureteral stents or nephrostomy tubes.
• Diabetes mellitus or immunosuppression (higher infection risk).
• Previous episodes of severe urinary or intra‑abdominal infection.

Diagnosis

Because symptoms are nonspecific, a systematic approach using imaging, endoscopy, and laboratory testing is essential.

Laboratory Tests

• Urinalysis & culture – may show mixed flora (enteric organisms) or fecal particles.
• Serum creatinine and BUN – assess renal function, which may be compromised.
• Complete blood count – look for leukocytosis indicating infection.

Imaging Studies

1. CT urography (CTU) – gold standard; high-resolution images reveal contrast extravasation from the ureter into the bowel lumen.
2. Retrograde pyelography – contrast injected through a ureteral catheter; directly visualizes the fistulous tract.
3. Magnetic resonance urography (MRU) – useful when radiation exposure is a concern.
4. Ultrasound – can detect hydronephrosis but is less sensitive for fistulas.

Endoscopic Evaluation

• Cystoscopy with ureteroscopy – enables direct visualization, guidewire placement, and possible stenting.
• Colonoscopy or sigmoidoscopy – if the colon is suspected, helps rule out other colonic pathology.

Diagnostic Criteria

A ureteroenteric fistula is confirmed when at least one of the following is demonstrated:

• Contrast passage from the ureter into the gastrointestinal lumen on imaging.
• Presence of urinary constituents (urea, creatinine) within bowel contents on laboratory analysis.
• Endoscopic identification of a fistulous opening.

Treatment Options

Management must be individualized based on the patient’s overall health, fistula location, and underlying cause.

Initial Stabilization

• Broad‑spectrum intravenous antibiotics covering Gram‑negative, Gram‑positive, and anaerobic organisms (e.g., piperacillin‑tazobactam or cefepime + metronidazole).
• Fluid resuscitation and correction of electrolyte abnormalities.
• Urinary diversion—percutaneous nephrostomy or ureteral stent—to decompress the kidney and reduce urine flow through the fistula.

Surgical Options

1. Ureteral Reimplantation – the diseased ureter segment is excised and re‑anastomosed to the bladder (or a continent reservoir) when the defect is short.
2. Ureteroureterostomy – ends of the ureter are joined after resecting the fistulous segment; often used when both sides are healthy.
3. Bowel Segment Resection and Primary Anastomosis – removal of the involved bowel portion with re‑connection; sometimes combined with urinary reconstruction.
4. Fistula Excision with Tissue Interposition – a vascularized flap (e.g., omental or muscle) placed between ureter and bowel to prevent recurrence.
5. Nephrectomy – reserved for non‑functional kidneys or when reconstruction is not feasible.

Minimally Invasive Techniques

• Endoscopic fulguration of the fistulous opening (rare, only for very small defects).
• Laparoscopic or robotic‑assisted repair – offers better visualization and faster recovery compared with open surgery.

Medical Management (Adjunct)

• Long‑term antibiotic suppression if definitive repair is delayed.
• Proton‑pump inhibitors or H2 blockers if reflux from the stomach/duodenum contributes.
• Nutrition support—high‑protein diet, possible enteral feeding—to improve wound healing.

Follow‑Up Care

After repair, patients typically undergo repeat imaging (CTU or retrograde pyelography) at 4–6 weeks to confirm closure, then periodic monitoring for at least 12 months.

Living with Ureteroenteric Fistula

Daily Management Tips

• Hydration – drink 2–3 L of water daily unless contraindicated; helps flush bacteria.
• Urinary hygiene – clean the perineal area gently after voiding; change any external drainage bags promptly.
• Stoma or nephrostomy care – follow catheter care protocols, keep the site dry, and inspect for redness or leakage.
• Dietary considerations – low‑residue, high‑protein meals to reduce bowel gas and support tissue repair.
• Monitor urine – note any color change, foul odor, or presence of bubbles, and report to your physician.
• Medication adherence – complete the full course of antibiotics and any prescribed pain relievers or anti‑inflammatories.
• Activity – avoid heavy lifting (> 10 kg) for 6 weeks post‑surgery; gentle walking is encouraged to improve circulation.

Psychosocial Support

Living with a rare fistula can be emotionally taxing. Consider joining support groups for patients with urinary diversion or fistula repair, and discuss any anxiety or depression with a mental‑health professional.

Prevention

• Meticulous surgical technique – intra‑operative ureteral identification (e.g., indocyanine‑green fluorescence) reduces accidental injury.
• Limit radiation dose to the lowest effective level; use intensity‑modulated radiotherapy (IMRT) to spare adjacent ureters.
• Prompt treatment of intra‑abdominal infections – early drainage and antibiotics prevent erosion into the ureter.
• Avoid long‑term indwelling stents unless medically necessary; replace or remove them per guidelines (usually every 3–6 months).
• Regular follow‑up after pelvic surgery – imaging at 3–6 months can detect early leaks before they become fistulas.

Complications

If left untreated, a ureteroenteric fistula can lead to serious health problems:

• Severe or recurrent urinary tract infections – may progress to pyelonephritis or sepsis.
• Renal impairment or loss – chronic obstruction and infection can cause irreversible kidney damage.
• Electrolyte disturbances – especially hyperkalemia from urine reabsorption in the bowel.
• Malnutrition – chronic diarrhea and protein loss.
• Fistula recurrence – up to 10 % after surgical repair; requires vigilant monitoring.
• Adverse impact on quality of life – odor, skin irritation, and psychosocial burden.

When to Seek Emergency Care

References

• Mayo Clinic. “Ureteroenteric Fistula: Diagnosis and Management.” 2022.
• American Urological Association. “Guidelines for Management of Urinary Tract Fistulas.” 2023.
• Cleveland Clinic. “Pelvic Radiation and Ureteral Injury.” 2021.
• National Institutes of Health (NIH). “Complications of Urinary Diversion.” 2020.
• World Health Organization. “Infection Prevention in Surgical Patients.” 2022.

```